Get notified when MNOV files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Immediate Dilution of $0.38 Per Share (new) — New investors pay $1.27 per share but receive only $0.89 in net tangible book value, an immediate loss of $0.38 per share.
MediciNova launches at-the-market offering of up to 39.37M shares at $1.27, raising $50M gross for the company
Filed December 30, 2025 · ~1 min read
Key Changes
-
high
MediciNova is selling up to 39,370,078 shares at an assumed price of $1.27 per share, for gross proceeds of $50.0 million to the company.
The Offering verify on EDGAR → -
high
New investors face immediate dilution of $0.38 per share, as net tangible book value rises to $0.89 from $0.59 after the offering.
Dilution verify on EDGAR → -
medium
Net proceeds will fund working capital, R&D, clinical trials, commercialization, and possible acquisitions, with broad management discretion.
Use of Proceeds verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (GIS 10-Q) is open in full — no account needed.
Partner
Trade MNOV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify